Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133590) titled 'Scalp Nerve Block with Liposomal Bupivacaine plus Bupivacaine Hydrochloride versus Bupivacaine Hydrochloride Alone for Postcraniotomy Pain: A Randomized Controlled Trial' on Sept. 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: PEKING UNIVERSITY SHENZHEN HOSPITAL
Condition:
Acute postcraniotomy pain
Intervention:
Bupivacaine hydrochloride group:Ultrasound-guided scalp nerve block with bupivacaine hydrochloride
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Bupivacaine hydrochloride group:30;Liposomal bupivacaine plus b...